Projects per year
Search results
-
Active
PP 2012190 Base Research Funds fase 2: PP 2012190 Base Research Funds fase 2
Derks, S. (Principal investigator)
01/01/2025 → 31/12/2027
Project: Research
-
Aspire grant: Epigenetic profiling and restoration of immune response to target gastroesophageal cancer
Derks, S. (Principal investigator)
01/01/2025 → 31/12/2025
Project: Research
-
Oncode TechDev: Overcoming Therapy Resistance in Gastric Cancer: Repurposed Drugs and Organoid Based Innovations.
Derks, S. (Principal investigator)
01/01/2025 → 31/12/2025
Project: Research
-
PP 33220 Memento Study (CCA): Metformin in esophageal adenocarcinomas: testing a metabolic intervention to improve response to neoadjuvant chemoradiotherapy
Derks, S. (Principal investigator)
Stichting Cancer Center Amsterdam
01/06/2024 → 31/05/2026
Project: Research
-
Memento Study (CCA): Metformin in esophageal adenocarcinomas: testing a metabolic intervention to improve response to neoadjuvant chemoradiotherapy
Derks, S. (Principal investigator)
Stichting Cancer Center Amsterdam
01/06/2024 → 31/05/2026
Project: Research
-
PP 31560 Pressure: PP 31560 Pressure sarah Derks
Derks, S. (Principal investigator)
European Research Council Executive Agency
01/02/2024 → 31/01/2028
Project: Research
-
Pressure MSCA: Pressure MSCA
Derks, S. (Principal investigator)
01/02/2024 → 31/01/2028
Project: Research
-
PP 31092 The React study: Reviving Gastro_Esophageal AdenoCarcinoma T cell immunity: the REACT study
Derks, S. (Principal investigator)
01/01/2024 → 31/12/2028
Project: Research
-
PP 33205 Legaat-Hol: Een onderzoek naar hoe door de tumor geproduceerde stoffen als VEGFA het succes van immuuntherapie kunnen beperken op zoek naar betere immuuncelstimulerende behandelingen
Derks, S. (Principal investigator)
Stichting Cancer Center Amsterdam
01/09/2023 → 31/08/2025
Project: Research
-
PP 31555 Base Res Funds fase 2: Base Research Funds Oncode Fase 2 - junior onderzoeker t.b.v. Sarah Derks
Derks, S. (Principal investigator)
01/01/2023 → 31/12/2027
Project: Research
-
PP 33145 CRISPR Legaat JG Ende: a CRISPR screen to find novel immunotargeting strategies in gastro-esophageal cancer
Derks, S. (Principal investigator)
Stichting Cancer Center Amsterdam
01/11/2021 → 31/10/2025
Project: Research
-
PP 33246 Pericode project: Finding regulatory mutations in the non-coding cancer genome.
Derks, S. (Principal investigator)
Antoni van Leeuwenhoek Ziekenhuis
01/09/2021 → 31/08/2027
Project: Research
-
Finished
HESTIA-project: The VEGFA-surpressed immune microenvironment and radiotherapy-sensitivity in esophageal adenocarcinomas
Derks, S. (Principal investigator)
NWO: Nederlandse Organisatie voor Wetenschappelijk Onderzoek
20/01/2020 → 19/07/2021
Project: Research
-
CCA Hestia Initiatief: Exploring the dynamic relationship between the tumor microenvironment and the response to radiotherapy in esophageal adenocarcinoma
Derks, S. (Principal investigator)
Stichting Cancer Center Amsterdam
20/01/2020 → 19/01/2024
Project: Research
-
PP 33127 Base Research Funds: Base Research Funding van Oncode voor Sarah Derks
Derks, S. (Principal investigator)
06/08/2019 → 31/12/2022
Project: Research
-
LEGACy (Sarah Derks): CeLac and European consortium for a personalized medicine approach to Gastric Cancer
Derks, S. (Principal investigator)
Fundacion Investigación Hospital General Universitario de Valencia
01/01/2019 → 30/06/2023
Project: Research